Biocon Biologics has comprehensive plan to integrate Viatris business: Shreehas Tambe, Biocon Biologics
"There are several other discussions that we have been having with private equity investors who are interested in making an investment in Biocon Biologics and that will help us bring down the $1.2 billion debt ... help us reduce the interest component that we see in the P&L," Shreehas Tambe, chief executive officer and managing director of Biocon Biologics, said in an interview.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
